HIGHLIGHTS
- who: Kimberly A. Kelly from the University of Virginia, MBerne Cardiovascular Research Center and the Biomedical Engineering Department, Charlottesville, Virginia, USA have published the research work: Development of Secreted Protein and Acidic and Rich in Cysteine (SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of Metastatic Prostate Cancer, in the Journal: (JOURNAL)
- what: The authors show that in vivo imaging information correlates with the potential of the tumor. The overall goal of this imaging nanoparticle is to reduce the number of unnecessary radical prostatectomies and, conversely, to ensure that highly invasive tumors are treated aggressively . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.